rs4774518
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_207581.4(DUOXA2):āc.738C>Gā(p.Tyr246*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000411 in 1,603,982 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Synonymous variant affecting the same amino acid position (i.e. Y246Y) has been classified as Benign.
Frequency
Consequence
NM_207581.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DUOXA2 | NM_207581.4 | c.738C>G | p.Tyr246* | stop_gained | 5/6 | ENST00000323030.6 | NP_997464.2 | |
DUOXA2 | XM_017022180.2 | c.789C>G | p.Tyr263* | stop_gained | 5/6 | XP_016877669.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DUOXA2 | ENST00000323030.6 | c.738C>G | p.Tyr246* | stop_gained | 5/6 | 1 | NM_207581.4 | ENSP00000319705.5 | ||
DUOXA2 | ENST00000491993.2 | n.*805C>G | non_coding_transcript_exon_variant | 5/6 | 1 | ENSP00000454110.1 | ||||
DUOXA2 | ENST00000491993.2 | n.*805C>G | 3_prime_UTR_variant | 5/6 | 1 | ENSP00000454110.1 | ||||
DUOXA2 | ENST00000350243.10 | n.1379C>G | non_coding_transcript_exon_variant | 4/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000143 AC: 34AN: 237622Hom.: 0 AF XY: 0.000162 AC XY: 21AN XY: 129994
GnomAD4 exome AF: 0.0000386 AC: 56AN: 1451624Hom.: 0 Cov.: 33 AF XY: 0.0000388 AC XY: 28AN XY: 720768
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152358Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74498
ClinVar
Submissions by phenotype
Thyroglobulin synthesis defect Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PVS1_Strong+PM3_VeryStrong+PP4+PP1 - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2008 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 27, 2022 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 31, 2021 | The c.738C>G (p.Y246*) alteration, located in exon 5 (coding exon 5) of the DUOXA2 gene, consists of a C to G substitution at nucleotide position 738. This changes the amino acid from a tyrosine (Y) to a stop codon at amino acid position 246. This alteration occurs at the 3' terminus of the DUOXA2 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 23.4% (75/320 amino acids) of the protein. However, premature stop codons are typically deleterious in nature and a significant portion of the protein is affected (Ambry internal data). This alteration has been reported in the homozygous state and in trans with a second DUOXA2 mutation in several patients with congenital hypothyroidism (Zamproni, 2008; Yi, 2013; Liu, 2015; Tanase-Nakao, 2018; Jung, 2020). In vitro studies showed reduced protein expression and inability to reconstitute DUOX2 activity, consistent with complete loss of function (Zamproni, 2008). Based on the available evidence, this alteration is classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at